Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 05, 2024

SELL
$9.77 - $21.47 $70,500 - $154,927
-7,216 Reduced 11.96%
53,113 $781,000
Q3 2023

Nov 06, 2023

BUY
$4.48 - $6.19 $270,273 - $373,436
60,329 New
60,329 $281,000
Q2 2021

Aug 05, 2021

SELL
$20.49 - $35.63 $291,121 - $506,231
-14,208 Reduced 56.59%
10,898 $293,000
Q1 2021

May 05, 2021

SELL
$18.99 - $33.2 $120,776 - $211,152
-6,360 Reduced 20.21%
25,106 $799,000
Q4 2020

Feb 04, 2021

BUY
$19.41 - $26.0 $610,755 - $818,116
31,466 New
31,466 $719,000
Q2 2019

Jul 29, 2019

SELL
$14.51 - $19.71 $346,281 - $470,379
-23,865 Closed
0 $0
Q1 2019

Apr 25, 2019

SELL
$11.11 - $25.6 $634,381 - $1.46 Million
-57,100 Reduced 70.52%
23,865 $429,000
Q4 2018

Feb 11, 2019

BUY
$11.75 - $21.42 $60,101 - $109,563
5,115 Added 6.74%
80,965 $1.03 Million
Q3 2018

Nov 05, 2018

BUY
$19.26 - $23.46 $891,160 - $1.09 Million
46,270 Added 156.42%
75,850 $1.63 Million
Q2 2018

Jul 31, 2018

BUY
$19.78 - $24.67 $585,092 - $729,738
29,580 New
29,580 $611,000
Q4 2017

Feb 05, 2018

SELL
$16.19 - $20.3 $505,289 - $633,563
-31,210 Closed
0 $0
Q3 2017

Nov 06, 2017

BUY
$15.52 - $18.94 $78,376 - $95,647
5,050 Added 19.3%
31,210 $577,000
Q2 2017

Aug 09, 2017

BUY
N/A
26,160
26,160 $458,000

Others Institutions Holding MGNX

About MACROGENICS INC


  • Ticker MGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,458,800
  • Market Cap $200M
  • Description
  • MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...
More about MGNX
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.